DJIA 16,919.59 80.85 0.48%
NASDAQ 4,527.51 19.20 0.43%
S&P 500 1,981.60 9.86 0.50%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

5.81 -0.06 (-1.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVNR $5.81 -1.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.93
Previous Close $5.87
Daily Range $5.79 - $5.94
52-Week Range $2.62 - $6.00
Market Cap $998.3M
P/E Ratio -12.49
Dividend (Yield) $0.00 (0.0%)
Volume 1,505,103
Average Daily Volume 1,847,950
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary

3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir

For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.

An Update On A Couple Of Small Biotech Plays

Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog

Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand - Analyst Blog

Avanir Pharmaceuticals' (AVNR) CEO Keith Katkin on Q3 2014 Results - Earnings Call Transcript

Avanir Pharmaceuticals (AVNR) Q3 2014 Results - Earnings Call Webcast

Insider Trading Alert - HERO, AVNR And CNMD Traded By Insiders

Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

3 Biotech Stocks Under $10 to Trade for Breakouts

Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog

See More AVNR News...

AVNR's Top Competitors

AVNR $5.81 (-1.02%)
Current stock: AVNR
NVS $88.63 (1.29%)
Current stock: NVS
PFE $28.94 (0.35%)
Current stock: PFE
JNJ $102.96 (0.25%)
Current stock: JNJ